Semaglutide offers flexibility with both a once-weekly injectable option and a once-daily oral tablet
It is sold strictly for research and educational purposes and is not intended to diagnose, treat, cure, or prevent any disease
Patients who inadvertently use expired semaglutide should: Monitor blood glucose levels closely (for diabetes patients) to detect any loss of glycemic control Watch for injection site reactions such as increased redness, warmth, swelling, or pain that could indicate infection Contact their healthcare provider to report the incident and obtain guidance on next steps Obtain a fresh supply and resume treatment with properly stored, unexpired medication Healthcare providers should emphasize the importance of adhering to expiration guidelines
Refer to the Peptide Reconstitution Guide and Peptide Storage Guide for handling reference
Relevant Its Me & You Clinic Peptides UK Resources Review the individual components before interpreting any commercial blend claim
It is produced by the pharmaceutical company Novo Nordisk
